§ Federal grant opportunity · RFA-NS-26-002
Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed). The deadline is Rolling / not published and the published award range is $3.5M – $4M.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- Rolling / not published
- Award range
- $3.5M – $4M
- Eligibility
- other native american tribal organizations, public and state institutions of higher education, federally recognized native american tribal governments, state governments, nonprofits non higher education with 501c3, special district governments, other, private institutions of higher education, for profit organizations other than small businesses, county governments, small businesses, public and indian housing authorities, city or township governments, independent school districts, nonprofits non higher education without 501c3
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-NS-26-002
Program overview
The National Institute of Neurological Disorders and Stroke (NINDS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to investigate novel therapeutic interventions and testing strategies for neurological disorders including to treat, modify, and prevent epilepsy. This research should include various intervention modalities and testing strategies. Investigators should consider testing strategies for the development and validation of human-focused testing approaches. Investigators with expertise and insights into preclinical therapy testing and model development are encouraged to consider applying for this new NOFO.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before Rolling / not published, allowing time for registration and validation.
Related grant opportunities
- NEI New Innovator Award (DP2 Clinical Trial Not Allowed)
- The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIJ FY 2026 Research on Gender Dysphoria and Violent Crime
- Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.